NCT01900899 - Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children | Biotech Hunter

Enrollment

184

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

Infections, Meningococcal

Interventions

PROCEDURE

Blood Sampling

At 2, 3, 4, 5, 6 years after booster vaccination.

Trial Locations (10)

Tampereen yliopisto/ Turun rokotetutkimusklinikka, Turku

Tampereen yliopisto/ Porin rokotetutkimusklinikka, Pori

Tampere Vaccine Research Clinic, Tampere

Tampereen Yliopisto/ Jarvenpaan rokotetutkimusklinikka, Järvenpää

Seinajoki Vaccine Research Clinic, Seinäjoki

Tampereen yliopisto/ Oulun rokotetutkimusklinikka, Oulu

Espoo Vaccine Research Clinic, Espoo

Tampereen yliopisto/ Etela-Helsingin rokotetutkimusklinikka, Helsinki

Helsinki East Vaccine Research Clinic, Helsinki

Tampereen yliopisto/ Ita-Vantaan rokotetutkimusklinikka, Vantaa